<div><strong>"I’ve spent my life serving others; now I’m fighting to stay for my kids."</strong>
</div>
<div><br />
</div>
<div>In 2023, Mark stood proudly with the Columbus Police Academy’s 141st class, ready to protect and serve. A Newark Catholic Hall of Famer (Class of '08) and an Ohio Dominican Alum ('12), Mark has always been defined by his strength, his heart, and his dedication to his faith, his family, his teammates, and the Reynoldsburg community. Whether he was on patrol or helping neighbors at the local food bank, Mark was the one people leaned on.
</div>
<div><br />
</div>
<div><strong>The Quiet Shift:</strong>
</div>
<div>The decline started subtly in April 2025. By July, a persistent "foot drop" began to hinder his stride. By September, the physical strength Mark relied on for his job began to fail him; spasticity led to falls, and the man who once patrolled our streets began needing a cane, then a walker.
</div>
<div><br />
</div>
<div><strong>The reality he faces is devastating:</strong>
</div>
<div>On January 8th, 2026, Mark and his family received the news no one is prepared for: a diagnosis of Amyotrophic Lateral Sclerosis (ALS).
</div>
<div><br />
</div>
<div>He is seeing a specialist at the Ohio State University every 3 months. They are tracking his progression by breathing tests.  
</div>
<div><br />
</div>
<div> ALS is a disease that slowly robs a person of their ability to move, speak, and eventually, to breathe and die from <strong>suffocation</strong>. But if you know Mark, you know he isn't a man who waits for the end. He is a man who fights for the beginning of a cure.
</div>
<div><br />
</div>
<div>Because there is currently no approved cure in the U.S., Mark is looking beyond our borders. He is tirelessly researching experimental trials overseas—breakthrough treatments that represent a lifeline.
</div>
<div><br />
</div>
<div><strong>The Mission: More Time, More Memories</strong>
</div>
<div><br />
</div>
<div>ALS is a relentless thief, but it hasn't stolen Mark’s spirit. At 35, Mark’s primary focus isn't himself—it's his three children (ages 7 to 16). He wants to be there to see them walk across the graduation stage, to be there for their weddings, and to remain the pillar of their lives for as long as possible.
</div>
<div><br />
</div>
<div>While the typical prognosis for ALS is 2-4 years, Mark is looking at the horizon. He is researching specialists across the globe, specifically looking toward cutting-edge treatments in Europe that offer hope for prolonging his life.
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Why We Need Your Help</strong>
</div>
<div><br />
</div>
<div>Mark is a man of service, and asking for help doesn't come naturally to him. However, the path to life-extending treatment is steep:
</div>
<div><br />
</div>
<div><strong>Mark’s research into overseas trials is a common path for those looking for "breakthrough" interventions not yet fully approved in the States.</strong>
</div>
<div><br />
</div>
<div>RNA-Based Gene Therapy (Israel): In late 2025, researchers in Israel announced a world-first using a specific RNA molecule (microRNA-126) that not only stopped nerve degeneration in models but showed signs of regeneration. This targets the TDP-43 protein, which is found in over 90% of all ALS cases.
</div>
<div><br />
</div>
<div>Stem Cell Therapy (Global): Various centers in Europe and Asia are testing Mesenchymal Stem Cells (MSCs). The goal here isn't just to replace dead neurons, but to create a "neuroprotective" environment that shields healthy nerves from dying.
</div>
<div><br />
</div>
<div>Pridopidine (Phase 3): A major global trial (PREVAiLS) is currently recruiting. It focuses on the Sigma-1 receptor to protect the "communication" between the brain and muscles.
</div>
<div><br />
</div>
<div><strong>The Mission: </strong>We are raising funds to get Mark access to experimental clinical trials currently taking place overseas. <strong>While the U.S. medical system provides incredible support, ALS moves fast—and we need to move faster.</strong>
</div>
<div><em>Travel Costs:</em> Funding for Mark to meet with world-renowned specialists overseas.
</div>
<div><br />
</div>
<div><em>Non-Covered Medical Advancements:</em> Many of the newest ALS treatments are considered "experimental" by insurance and must be paid for out-of-pocket.
</div>
<div><br />
</div>
<div><em>Family Security:</em> Ensuring Mark can pursue every possible medical avenue without plunging his children’s future into debt.
</div>
<div><br />
</div>
<div><strong>How You Can Help</strong>
</div>
<div><br />
</div>
<div>Whether you know him as "Officer Nichols," a teammate from his Newark Catholic days, or a friendly face from the Reynoldsburg Food Bank, you know he would give you the shirt off his back.
</div>
<div><br />
</div>
<div><strong>Donate:</strong> No amount is too small. Every dollar is a "thank you" for his service and a "yes" to more time with his kids.
</div>
<div><br />
</div>
<div><strong>Share:</strong> Please post this link on Facebook, in Police Union groups, and among the Newark/Columbus alumni networks.
</div>
<div><br />
</div>
<div><strong>Pray &amp; Support:</strong> Keep Mark, his children, and his family in your thoughts and prayers.
</div>

stefanie brooker

Kelton Blohm

Ed Hatrick

Kevin Hatrick

Jalynn Williams

Liz Wipper

zach shemancik

Brent Wahle

Anonymous

Glenn Wirth

Maria DeVito

Joseph Potts

Cathy Schumaker

Debbie Bickle

TOM AND SALLY HAYCOOK

Standing with Officer Nichols: A Hero's Fight Against ALS

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Eligible for Profile Comment Badge

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

isEligibleForProfileCommentBadge

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Standing with Officer Nichols: A Hero's Fight Against ALS

Still $4,755 to go. Help us build momentum.